Bluefin Capital Management’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-48,100
Closed -$241 282
2022
Q4
$241 Sell
48,100
-17,200
-26% -$23K ﹤0.01% 483
2022
Q3
$2K Sell
65,300
-63,100
-49% -$165K ﹤0.01% 509
2022
Q2
$7K Sell
128,400
-17,700
-12% -$47K ﹤0.01% 509
2022
Q1
$60K Sell
146,100
-76,800
-34% -$223K 0.01% 452
2021
Q4
$13K Sell
222,900
-37,600
-14% -$231K ﹤0.01% 782
2021
Q3
$170K Sell
260,500
-298,700
-53% -$2.56M 0.02% 482
2021
Q2
$1.21M Buy
559,200
+313,500
+128% +$3.08M 0.08% 167
2021
Q1
$80K Buy
+245,700
New +$2.77M ﹤0.01% 575

Other funds holding CLOV

Bluefin Capital Management's CLOV Position: Q2 2022 in Review

Bluefin Capital Management sold out of Clover Health Investments (CLOV) in Q2 2022, closing a stake of 57,207 shares — an estimated $152K sold.

Bluefin Capital Management first reported a position in CLOV in Q2 2020 and held it in 4 quarters. The position peaked at $1.96M in Q2 2020. 176 funds tracked by Wall St. Rank hold CLOV as of Q2 2022.

  • Bluefin Capital Management reported no remaining Clover Health Investments position as of Q2 2022 after selling out during the quarter.
  • Bluefin Capital Management sold 57,207 Clover Health Investments shares in Q2 2022, an estimated $152K.
  • Bluefin Capital Management first reported a position in Clover Health Investments in Q2 2020 and held it in 4 quarters.
  • Bluefin Capital Management's Clover Health Investments position peaked at $1.96M in Q2 2020.
  • 176 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2022.

Based on Bluefin Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.